These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

424 related articles for article (PubMed ID: 9988508)

  • 21. In vitro and in vivo evaluation of antifungal agents.
    Espinel-Ingroff A; Shadomy S
    Eur J Clin Microbiol Infect Dis; 1989 Apr; 8(4):352-61. PubMed ID: 2497014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Empirical antifungal therapy in treating febrile neutropenic patients.
    Wingard JR
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S38-43. PubMed ID: 15250019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal use of the newer antifungal agents.
    Helwick C
    Oncology (Williston Park); 2000 Sep; 14(9):1262-4. PubMed ID: 11033823
    [No Abstract]   [Full Text] [Related]  

  • 25. Drugs for treatment of fungal infections.
    Med Lett Drugs Ther; 1992 Feb; 34(864):14-6. PubMed ID: 1310518
    [No Abstract]   [Full Text] [Related]  

  • 26. Empirical versus preemptive antifungal therapy for high-risk, febrile, neutropenic patients: a randomized, controlled trial.
    Cordonnier C; Pautas C; Maury S; Vekhoff A; Farhat H; Suarez F; Dhédin N; Isnard F; Ades L; Kuhnowski F; Foulet F; Kuentz M; Maison P; Bretagne S; Schwarzinger M
    Clin Infect Dis; 2009 Apr; 48(8):1042-51. PubMed ID: 19281327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current role of amphotericin B lipid complex in managing systemic fungal infections.
    Chu P; Sadullah S
    Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Choice and use of antifungal drugs].
    Dupont B
    Rev Prat; 2001 Apr; 51(7):752-7. PubMed ID: 11387672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antimycotic therapy].
    Schaffner A
    Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antifungal treatment in pediatric patients.
    Zaoutis TE; Benjamin DK; Steinbach WJ
    Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New antifungal agents.
    Graybill JR
    Eur J Clin Microbiol Infect Dis; 1989 May; 8(5):402-12. PubMed ID: 2546775
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapy of systemic candidiasis].
    Meunier F
    Mycoses; 1994; 37 Suppl 2():52-5. PubMed ID: 7609744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of voriconazole, itraconazole, fluconazole and amphotericin B in vitro against 1763 yeasts from 472 patients in the voriconazole phase III clinical studies.
    Johnson E; Espinel-Ingroff A; Szekely A; Hockey H; Troke P
    Int J Antimicrob Agents; 2008 Dec; 32(6):511-4. PubMed ID: 18790613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Posaconazole: an extended-spectrum triazole antifungal agent.
    Schiller DS; Fung HB
    Clin Ther; 2007 Sep; 29(9):1862-86. PubMed ID: 18035188
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strategies in the treatment of systemic fungal infections.
    Medoff G; Kobayashi GS
    N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703
    [No Abstract]   [Full Text] [Related]  

  • 36. Posaconazole: clinical pharmacology and potential for management of fungal infections.
    Groll AH; Walsh TJ
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):467-87. PubMed ID: 16107193
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drugs for treatment of deep fungal infection.
    Med Lett Drugs Ther; 1988 Mar; 30(761):30-2. PubMed ID: 3343965
    [No Abstract]   [Full Text] [Related]  

  • 38. [Flucytosine - a classical partner for combination therapy].
    Polak A
    Mycoses; 2002; 45 Suppl 3():31-3. PubMed ID: 12690968
    [No Abstract]   [Full Text] [Related]  

  • 39. New investigational antifungal agents for treating invasive fungal infections.
    Hossain MA; Ghannoum MA
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1797-813. PubMed ID: 11060778
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of severe fungal infections].
    Battegay M; Flückiger U
    Internist (Berl); 2003 Dec; 44(12):1549-56. PubMed ID: 14689198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.